Facilitated By

San Antonio Medical Foundation

A MULTICENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, MULTIPLE DOSE, CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF MNK-1411 IN MALE SUBJECTS 4 TO 8 YEARS OF AGE WITH DUCHENNE MUSCULAR DYSTROPHY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bhavaraju-Sanka, Ratna K.
Funded by
MALLINCKRODT PHARMACEUTICALS
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Other